CRIS Current Research Information System

CORINALDESI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.841
AS - Asia 10.643
EU - Europa 8.792
AF - Africa 592
SA - Sud America 527
OC - Oceania 31
Continente sconosciuto - Info sul continente non disponibili 6
AN - Antartide 1
Totale 34.433
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.679
VN - Vietnam 3.225
SG - Singapore 2.687
CN - Cina 2.626
GB - Regno Unito 2.345
IT - Italia 1.471
DE - Germania 1.246
SE - Svezia 775
HK - Hong Kong 752
UA - Ucraina 600
FR - Francia 528
IN - India 458
RU - Federazione Russa 405
BR - Brasile 371
FI - Finlandia 298
IE - Irlanda 298
CH - Svizzera 210
JP - Giappone 179
NL - Olanda 178
ZA - Sudafrica 142
EE - Estonia 137
KR - Corea 137
TG - Togo 131
CI - Costa d'Avorio 115
BD - Bangladesh 105
NG - Nigeria 96
CA - Canada 94
JO - Giordania 82
PH - Filippine 75
AT - Austria 70
AR - Argentina 60
BG - Bulgaria 56
SC - Seychelles 53
TH - Thailandia 49
BE - Belgio 35
IQ - Iraq 35
ID - Indonesia 34
AU - Australia 30
MX - Messico 30
TW - Taiwan 29
EC - Ecuador 28
IR - Iran 28
PL - Polonia 27
TR - Turchia 27
GR - Grecia 23
PK - Pakistan 20
SA - Arabia Saudita 19
CL - Cile 18
HR - Croazia 16
UZ - Uzbekistan 15
CO - Colombia 14
ES - Italia 14
LB - Libano 13
LT - Lituania 12
RO - Romania 12
EG - Egitto 11
PY - Paraguay 11
TN - Tunisia 11
MA - Marocco 10
MY - Malesia 9
PE - Perù 9
CZ - Repubblica Ceca 8
DZ - Algeria 7
JM - Giamaica 7
AE - Emirati Arabi Uniti 6
IL - Israele 6
UY - Uruguay 6
VE - Venezuela 6
GH - Ghana 5
HU - Ungheria 5
PT - Portogallo 5
SK - Slovacchia (Repubblica Slovacca) 5
A2 - ???statistics.table.value.countryCode.A2??? 4
CR - Costa Rica 4
GT - Guatemala 4
NP - Nepal 4
OM - Oman 4
SV - El Salvador 4
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
KW - Kuwait 3
NI - Nicaragua 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
HN - Honduras 2
KH - Cambogia 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MU - Mauritius 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AM - Armenia 1
Totale 34.411
Salva come PNG Salva come JPEG
Città #
Southend 2.079
Houston 1.998
Singapore 1.812
Ashburn 1.240
Fairfield 1.012
Dong Ket 868
Chandler 770
Hong Kong 699
San Jose 649
Santa Clara 561
Ho Chi Minh City 544
Hanoi 521
Woodbridge 508
Wilmington 464
Seattle 461
Jacksonville 396
Princeton 385
Ann Arbor 352
Cambridge 351
Hefei 335
Beijing 334
Munich 310
Dublin 294
Boardman 264
Helsinki 261
New York 223
Los Angeles 202
Bern 190
Padova 181
Lauterbourg 171
Westminster 168
Nanjing 167
Council Bluffs 151
Tokyo 138
Berlin 136
Bologna 134
Milan 134
Lomé 131
Abidjan 115
Seoul 105
Dallas 100
Buffalo 99
Jinan 96
Shenyang 86
Amman 81
Rome 77
Haiphong 76
Changsha 75
Guangzhou 75
Saint Petersburg 75
Mülheim 73
Da Nang 72
Bremen 69
Abeokuta 64
Shanghai 64
Tianjin 59
San Diego 58
Medford 57
São Paulo 57
Nanchang 54
Sofia 54
Florence 52
Washington 52
Hebei 50
Vienna 46
Turin 44
Frankfurt am Main 43
Redondo Beach 43
Phoenix 42
Mahé 40
Dearborn 39
Bengaluru 38
Haikou 37
Toronto 36
Yubileyny 35
Falls Church 34
Des Moines 33
San Francisco 32
Verona 32
Zhengzhou 32
Hyderabad 31
Hangzhou 30
Ningbo 30
Orem 30
Brussels 28
Hải Dương 27
Atlanta 26
Shenzhen 26
Biên Hòa 25
Chicago 25
Falkenstein 25
London 25
Jiaxing 24
Lagos 24
Montreal 24
Norwalk 24
Taizhou 24
Fuzhou 23
Bắc Ninh 22
Can Tho 22
Totale 22.610
Salva come PNG Salva come JPEG
Nome #
New pathophysiological mechanisms in irritable bowel syndrome. 1.817
Seasonal pattern of peptic ulcer hospitalizations: analysis of the hospital discharge data of the Emilia-Romagna region of Italy. 556
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 433
Chronic Intestinal Pseudo-Obstruction: A Neuropathological Approach 364
La sindrome dell'intestino irritabile. 351
Acute pancreatitis due to simvastatin therapy: increased severity after rechallenge. 332
Randomised controlled trial of mesalazine in IBS 325
Salmonella gastroenteritis during childhood is a risk factor for irritable bowel syndrome in adulthood 314
Molecular and Pathological characterization of a non-aganglionic congenital megacolon in the rabbit 307
Chronic intestinal pseudo-obstruction related to viral infections. 304
Il sistema nervoso enterico. 302
Use of macrogol 4000 in chronic constipation. 284
Abnormalities of somatic peptide-containing nerves supplying the pelvic floor of women with genitourinary prolapse and stress urinary incontinence. 278
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: a single center prospective, randomized controlled study. 259
Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons 259
Sigmoid compliance and visceral perception in spinal cord injury patients 246
Diagnosis and therapy of irritable bowel syndrome 242
Anti-ganglioside antibodies in coeliac disease with neurological disorders. 241
Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. 238
A-Transducin, a Signaling Molecule of the Chemoreceptive Cascade, Is Expressed in Endocrine and Non-Endocrine Cells of the Pig Gastrointestinal Mucosa 236
Basis for treatment of functioning neuroendocrine tumours. 234
Chronic intestinal pseudo-obstruction: manifestations, natural history and management. 231
A novel locus for syndromic chronic idiopathic intestinal pseudo-obstruction maps to chromosome 8q23-q24. 231
Altered Serotonin Signaling and Extrinsic Sensory Neuron Activation in Irritable Bowel Syndrome 227
Chromogranin A: is it a useful marker of neuroendocrine tumors? 225
New insights into human enteric neuropathies. 222
Adult coeliac disease diagnosed by endoscopic biopsies in the duodenal bulb. 222
Contrast-enhanced ultrasound in the differential diagnosis of exocrine versus neuroendocrine pancreatic tumors 222
L’encefalomiopatia Mitocondriale Neurogastrointestinale (MNGIE): Il Fegato Come Nuova Fonte Di Timidina Fosforilasi 221
Chemosensitività intestinale, nervi, cellule enteroendocrine, recettori del gusto 219
Chronic asymptomatic pancreatic hyperenzymemia is a benign condition in only half of the cases: a prospective study 219
Endocrine pancreatic tumors: factors correlated with survival. 218
A case of primary pancreatic lymphoma. 216
Intestinal serotonin release, sensory neuron activation, and abdominal pain in irritable bowel syndrome. 216
The immune system in irritable bowel syndrome. 216
Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome. 214
Chronic intestinal pseudo-obstruction. 210
The ELISA fecal elastase-1 polyclonal assay reacts with different antigens than those of the monoclonal assay. 207
MALATTIA DA REFLUSSO GASTROESOFAGEO 205
Duodenal histology in patients with celiac disease after a gluten-free diet 201
JC virus infects the enteric glia of patients with chronic idiopathic intestinal pseudo-obstruction. 199
Expression and regulation of α-transducin in the pig gastrointestinal tract 193
Interstitial lung disease (ILD) and gastroesophageal reflux (GER) 192
Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome 190
Neuroplasticity of the enteric nervous system induced by inflammatory conditions in the gut 188
Endocrine tumors of the ileum: factors correlated with survival. 188
Paraneoplastic Syndrome 185
Gut microbiota and related diseases: clinical features. 185
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 185
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 184
Pancreatic involvement in systemic sarcoidosis. A case report. 184
Gastroesophageal reflux disease: clinical and pathophysiological features (part I)] 184
Advances in our understanding of the pathology of chronic intestinal pseudo-obstruction. 184
Caratterizzazione genetico-molecolare e morfologica di un modello sperimentale di megacolon congenito non agangliare. 183
Evidence of RET/GDNF-related apolipoprotein B (APOB) activation and altered expression in patients with chronic intestinal pseudo-obstruction (CIPO) 183
Almost all irritable bowel syndromes are post-infectious and respond to probiotics: controversial issues. 183
Aspetti clinici ed anticorpi anti-neurone nella malattia celiaca con disordini neurologici 181
Post-infectious Irritable Bowel Syndrome. 180
Enteroendocrine profile of α-transducin immunoreactive cells in the gastrointestinal tract of the European sea bass (Dicentrarchus labrax) 180
Gastroesophageal reflux disease: therapeutic features (Part II)] 178
Neuroplasticità gastroenterica: dai geni all’infiammazione. 177
Medical treatment of endocrine gastroenteropancreatic tumors. 176
Chronic intestinal pseudo-obstruction: clinical features, diagnosis, and therapy. 176
Zollinger-Ellison syndrome. Diagnosis and therapy. 175
Gastro-oesophageal reflux and interstitial lung disease. 175
Water-related techniques in colonoscopy: the end justifies the means! 174
Interactions between commensal bacteria and gut sensorimotor function in health and disease. 173
Enteric neuroplasticity evoked by inflammation 172
Clinical approach to diarrhea 171
Enteric neuropathy evoked by repeated cisplatin in the rat. 169
A case of paraneoplastic inflammatory neuropathy of the gastrointestinal tract related to an underlying neuroblastoma: successful management with immunosuppressive therapy. 169
Plasma acylated ghrelin levels are higher in patients with chronic atrophic gastritis. 168
Antiflagellin antibodies suggest infective participation in irritable bowel syndrome pathogenesis. 168
Unsolved problems in the management of patients with gastro-oesophageal reflux disease 167
Mast cell neuromuscolar involvement in patients with severe gastrointestinal dysmotility (SGID). 167
Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. 167
Actual therapy of gastroesophageal reflux disease 166
Quality of life in patients with chronic pancreatitis 165
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 165
Delayed gastric emptying in functional dyspepsia 164
La malattia da reflusso gastroesofageo. 164
Sympathetic hyperactivity in patients with ulcerative colitis. 164
Sedation during colonoscopy and the benefits of lubrication 164
How to proceed in H pylori-positive chronic gastritis refractory to first and second line eradication therapy. 164
Malattia da reflusso gastroesofageo. 164
Enteric neuron involvement in dysmotilities and responses to inflammation. 163
Chronic intestinal pseudo-obstruction. 162
Inflammatory neuropathies of the enteric nervous system 159
Molecular genetics of human enteric neuropathies. 158
Mucosal permeability and immune activation as potential therapeutic targets of probiotics in irritable bowel syndrome. 158
Lubrication during colonoscopy: a forgotten factor. 157
Does colorectal endometriosis alter intestinal functions? A prospective manometric and questionnaire-based study. 156
Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. 156
Routine duodenal biopsies: is it time to change our minds? 155
Quality of life and clinical indicators for chronic pancreatitis patients in a 2-year follow-up study. 155
Review article: molecular, pathological and therapeutic features of human enteric neuropathies 155
Patient-reported outcomes and gut dysmotility in functional gastrointestinal disorders. 154
A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation (IBS-C). 152
Postinfectious irritable bowel syndrome. 151
Assessment of the quality of life in chronic pancreatitis using Sf-12 and EORTC Qlq-C30 questionnaires. 151
Totale 22.339
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.430
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.430
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.097 0 0 0 0 0 0 0 0 0 0 0 1.097
2021/20224.003 524 115 237 212 274 177 78 210 110 200 1.298 568
2022/20233.852 367 535 229 483 265 254 94 244 640 124 280 337
2023/20241.338 106 190 130 121 143 351 65 54 20 44 59 55
2024/20254.541 179 591 461 254 861 323 454 260 149 201 105 703
2025/20269.882 730 945 892 620 1.163 561 1.017 312 2.054 712 495 381
Totale 34.854